Gil Ben-Menachem

Title: Gil Ben-Menachem: Innovator in Glycobiology

Introduction

Gil Ben-Menachem is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of glycobiology, particularly in the development of methods for conjugating oligosaccharides and polysaccharides to protein carriers. With a total of 2 patents, his work has implications for immunogenic conjugates and therapeutic applications.

Latest Patents

Ben-Menachem's latest patents include innovative methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid. These methods involve obtaining an oligosaccharide or polysaccharide with a KDO moiety at the terminal reducing end, which includes a carbonyl functional group. The process entails reacting this carbonyl functional group with an aminooxylated protein carrier molecule, resulting in a conjugate that features a covalent oxime bond between the oligosaccharide or polysaccharide and the protein carrier. Additionally, he has developed unique compounds that can induce an immune response in subjects, particularly useful for preventing or treating Lyme disease.

Career Highlights

Throughout his career, Ben-Menachem has worked with esteemed organizations, including the United States Department of Health and Human Services and the National Research Council of Canada. His expertise in glycobiology has positioned him as a key figure in the development of immunogenic compositions.

Collaborations

He has collaborated with notable colleagues such as Joanna Kubler-Kielb and Vince Pozsgay, contributing to advancements in his field.

Conclusion

Gil Ben-Menachem's innovative work in glycobiology and his contributions to immunogenic conjugates highlight his importance as an inventor. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic strategies.